List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 58 studies with search of: cervical cancer AND new jersey
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Terminated Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: isotretinoin;   Drug: paclitaxel
2 Recruiting Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Drug: paclitaxel;   Drug: topotecan hydrochloride
3 Recruiting Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Condition: Cervical Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
4 Active, not recruiting Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Condition: Cancer
Intervention: Biological: therapeutic allogeneic lymphocytes
5 Recruiting Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: brivanib alaninate;   Other: laboratory biomarker analysis
6 Recruiting Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: topotecan hydrochloride;   Drug: veliparib;   Other: laboratory biomarker analysis
7 Completed Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: celecoxib;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: brachytherapy;   Radiation: radiation therapy
8 Unknown † Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Conditions: Cervical Cancer;   Endometrial Cancer
Interventions: Drug: cisplatin;   Radiation: intensity-modulated radiation therapy
9 Completed Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: radiation therapy
10 Unknown † Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: topotecan hydrochloride;   Drug: vinorelbine tartrate
11 Recruiting Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: intensity-modulated radiation therapy
12 Completed Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Intervention: Drug: erlotinib hydrochloride
13 Active, not recruiting ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Genetic: protein expression analysis;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis
14 Completed Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Intervention: Biological: recombinant interleukin-12
15 Completed Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: isosulfan blue;   Drug: methylene blue;   Procedure: conventional surgery;   Procedure: laparoscopic surgery;   Procedure: lymphangiography;   Procedure: radionuclide imaging;   Procedure: sentinel lymph node biopsy;   Radiation: technetium Tc 99m sulfur colloid
16 Completed Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: vincristine sulfate;   Procedure: surgical procedure;   Radiation: radiation therapy
17 Completed Radiation Therapy and Cisplatin With or Without Amifostine in Treating Patients With Stage IIIB or Stage IVA Cancer of the Cervix
Conditions: Cervical Cancer;   Radiation Toxicity
Interventions: Drug: amifostine trihydrate;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: radiation therapy
18 Active, not recruiting Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease in Women Undergoing Routine Cervical Cancer Screening Using Cervical Samples Prepared With the COBAS X421 Instrument
Condition: Human Papilloma Virus (HPV)
Intervention: Device: Cobas® 4800 HPV Test
19 Unknown † Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
Condition: Cervical Cancer
Intervention: Procedure: conventional surgery
20 Completed Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Radiation: brachytherapy;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services